Skip to main content
. 2016 Feb 2;75(3):239–245. doi: 10.1093/jnen/nlv023

FIGURE 4.

FIGURE 4.

Quantitative immunohistochemistry for LC3, p62, and TDP-43: sporadic inclusion body myositis (sIBM) to HIV-inclusion body myositis (HIV-IBM) comparison. (A–C) There was no significant difference in the percentage of (A) LC3-, (B) p62-, and (C) TDP-43-positive fibers between patients with sIBM and HIV-IBM; the sIBM cohort data were reported previously (14). Each biopsy is represented with a symbol; the lines designate group means.